scispace - formally typeset
F

Francesco Negrini

Researcher at University of Milan

Publications -  46
Citations -  1100

Francesco Negrini is an academic researcher from University of Milan. The author has contributed to research in topics: Rehabilitation & Medicine. The author has an hindex of 14, co-authored 38 publications receiving 549 citations.

Papers
More filters
Journal ArticleDOI

Early rehabilitation in post-acute COVID-19 patients: data from an Italian COVID-19 Rehabilitation Unit and proposal of a treatment protocol.

TL;DR: It is suggested that post-acute COVID-19 patients suffered from dyspnoea and shortness of breath even for minimal activities, with a resulting severe disability, and only a few of them were able to perform 6-MWT with poor results.
Journal ArticleDOI

Systematic rapid "living" review on rehabilitation needs due to COVID-19: update to March 31st, 2020.

TL;DR: This systematic rapid living review showed an increasing evidence on rehabilitation needs due to COVID-19 outbreak during April 2020, with the first appearance of epidemiological data on the likely high incidence of neurological complications/disabling sequelae in patients hospitalized for CO VID-19.
Journal ArticleDOI

Rehabilitation and COVID-19: the Cochrane Rehabilitation 2020 rapid living systematic review.

TL;DR: It is advised to test for COVID-19 people with neurological disorders presenting with symptom changes and there is only sparse and low quality evidence concerning the efficacy of any rehabilitation intervention to promote functional recovery.
Journal ArticleDOI

Neuropsychological Features of Severe Hospitalized Coronavirus Disease 2019 Patients at Clinical Stability and Clues for Postacute Rehabilitation.

TL;DR: The results indicate that some COVID-19 patients might also benefit from a neuropsychological rehabilitation, given their possible global cognitive decay, and suggest that neurocognitive rehabilitative treatments should be directed explicitly towards patients who are treated in the ICU care, rather than towards every patient who suffered from acute respiratory distress syndrome due to CO VID-19.